Kinvestor
News
Markets
Earnings
Insider
Portfolio
Pricing
Get Started
REGN
Regeneron Pharmaceuticals Inc
Biotechnology
+ Watchlist
View SEC Filings
Overview
Financials
Earnings
Insider
Ownership
Filings
News
Regeneron Pharmaceuticals Inc (REGN) Earnings
Last reported
April 29, 2026
EPS estimate
$9.23
EPS actual
—
Revenue est.
$3.6B
Revenue actual
—
Related:
REGN overview
·
REGN financials
·
REGN news